A shortage of funding or not enough healthcare projects?
<img src=" https://s3.amazonaws.com/production.scholastica/article/124008/large/lou.jpg?1727462674"> The author, having worked in pharmaceuticals for several decades, has advised, in confidence, both investors and small to medium-sized enterprises on transitioning healthcare research...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Andover House Inc.
2024-09-01
|
| Series: | Precision Nanomedicine |
| Online Access: | https://doi.org/10.33218/001c.124008 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841557954578350080 |
|---|---|
| author | Mike Eaton |
| author_facet | Mike Eaton |
| author_sort | Mike Eaton |
| collection | DOAJ |
| description | <img src=" https://s3.amazonaws.com/production.scholastica/article/124008/large/lou.jpg?1727462674">
The author, having worked in pharmaceuticals for several decades, has advised, in confidence, both investors and small to medium-sized enterprises on transitioning healthcare research projects into commercial development, mainly in Europe. He is now semi-retired. This note is written in the hope that his experience will improve the success of small and medium-sized enter-prises in their attempts to get non-academic investment funding and make life easier for investors. Whilst focused on drugs, the broader advice is relevant to other healthcare areas, such as diagnostics and devices. |
| format | Article |
| id | doaj-art-e237384bd4c144b9877c44a3c5dd1ca3 |
| institution | Kabale University |
| issn | 2639-9431 |
| language | English |
| publishDate | 2024-09-01 |
| publisher | Andover House Inc. |
| record_format | Article |
| series | Precision Nanomedicine |
| spelling | doaj-art-e237384bd4c144b9877c44a3c5dd1ca32025-01-06T09:18:26ZengAndover House Inc.Precision Nanomedicine2639-94312024-09-0173A shortage of funding or not enough healthcare projects?Mike Eaton<img src=" https://s3.amazonaws.com/production.scholastica/article/124008/large/lou.jpg?1727462674"> The author, having worked in pharmaceuticals for several decades, has advised, in confidence, both investors and small to medium-sized enterprises on transitioning healthcare research projects into commercial development, mainly in Europe. He is now semi-retired. This note is written in the hope that his experience will improve the success of small and medium-sized enter-prises in their attempts to get non-academic investment funding and make life easier for investors. Whilst focused on drugs, the broader advice is relevant to other healthcare areas, such as diagnostics and devices.https://doi.org/10.33218/001c.124008 |
| spellingShingle | Mike Eaton A shortage of funding or not enough healthcare projects? Precision Nanomedicine |
| title | A shortage of funding or not enough healthcare projects? |
| title_full | A shortage of funding or not enough healthcare projects? |
| title_fullStr | A shortage of funding or not enough healthcare projects? |
| title_full_unstemmed | A shortage of funding or not enough healthcare projects? |
| title_short | A shortage of funding or not enough healthcare projects? |
| title_sort | shortage of funding or not enough healthcare projects |
| url | https://doi.org/10.33218/001c.124008 |
| work_keys_str_mv | AT mikeeaton ashortageoffundingornotenoughhealthcareprojects AT mikeeaton shortageoffundingornotenoughhealthcareprojects |